RG7204
Roche weathers tough year and looks to pipeline for 2011
February 3, 2011Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
Trial success for Roche’s personalised skin cancer drug
January 19, 2011Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer
A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …
Roche’s melanoma candidate impresses in phase II trials
November 5, 2010Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche
Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
